Enright Patrick G: insider buys
Every open-market stock purchase reported by Enright Patrick G to the SEC on Form 4.
Total bought$20.78M
Purchases3
Companies3
Last purchase filedFeb 5, 2026
Return on these buys+40%
Enright Patrick G has made 3 open-market purchases worth $20.78M in 3 companies since Oct 14, 2025, according to SEC Form 4 filings. The most recent was filed on Feb 5, 2026: 1,075,000 shares of MANE at $17.00 (Director, 10% Owner), worth $18.27M. Taken together, these purchases are up 40% at the latest closing prices (split-adjusted, weighted by amount).
Companies Enright Patrick G bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| MANE | Veradermics, Inc | Director, 10% Owner | 1 | $18.27M | — | Feb 5 |
| ZBIO | Zenas BioPharma, Inc. | Director | 1 | $2.25M | +48% | Oct 14 |
| VERA | Vera Therapeutics, Inc. | Director | 1 | $249.99K | -27% | Dec 15 |
Get the next Enright Patrick G purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5 | MANEVeradermics, Inc | Enright Patrick GDirector, 10% Owner | $18.27M | 1,075,000 | $17.00 | — | +70% | Feb 5 | SEC |
| Dec 15 | VERAVera Therapeutics, Inc. | Enright Patrick GDirector | $249.99K | 5,882 | $42.50 | -27% | new | Dec 11 | SEC |
| Oct 14 | ZBIOZenas BioPharma, Inc. | Enright Patrick GDirector | $2.25M | 117,255 | $19.19 | +48% | — | Oct 9 | SEC |